查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球診斷設備市場 - 2023-2030年
市場調查報告書
商品編碼
1297772

全球診斷設備市場 - 2023-2030年

Global Diagnostic Device Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球診斷設備市場在2022年達到470億美元，預計到2030年將見證有利可圖的成長，達到799億美元。在2023-2030年的預測期間，市場預計將呈現6.9%的複合成長率。

診斷設備通過實現早期檢測、準確診斷、監測疾病、個性化治療、公共衛生監測和研究，在醫療保健中發揮著關鍵作用。診斷設備提供客觀和精確的資訊，協助醫療專業人士做出準確的診斷。診斷設備能夠對疾病和狀況進行長期監測，幫助醫療服務提供者評估治療效果並做出必要的調整。

市場動態

慢性病發病率的上升正在推動診斷設備市場的成長。

慢性病是長期的健康問題，需要持續管理和醫療護理。它們是世界範圍內的主要健康問題，對個人、醫療系統和社會有著深遠的影響。慢性病是全世界死亡和殘疾的最大原因。

據世界衛生組織（WHO）稱，非傳染性疾病（NCDs），包括心血管疾病、癌症、慢性呼吸道疾病和糖尿病等慢性疾病，佔全球所有死亡的近75%。另一方面，糖尿病是一種以血糖水平升高為特徵的慢性代謝性疾病。

根據國際糖尿病聯合會的數據，2019年大約有4.63億成年人（20-79歲）患有糖尿病，如果目前的趨勢繼續下去，這個數位預計到2045年將攀升至7億。而這些因素促成了市場的擴張。

昂貴的程序和設備將阻礙市場的成長。

診斷設備的成本會因各種因素而有很大差異，包括設備的類型、其複雜性、功能、品牌和購買的地區。例如，超聲機使用聲波來產生身體內部結構的圖像。超音波機的成本可以有很大的不同，這取決於其預期用途和功能。攜帶式或手持式超聲設備可能從3000美元到15000美元不等，而醫療機構使用的高階、基於推車的系統可能需要數万或更多。因而程序的成本將阻礙市場的成長。

COVID-19影響分析

COVID-19的大流行對診斷設備及其使用產生了廣泛影響。例如，這場大流行促使人們對COVID-19診斷測試產生了迄今為止聞所未聞的需求。 COVID-19的感染已經用診斷工具，如PCR設備和快速抗原測定法進行檢測和診斷。檢測需求的增加使這些設備的製造和使用在世界範圍內得到了提高。

COVID-19大流行對診斷設備的格局產生了重大影響，導致需求增加、技術進步、供應鏈問題、重點轉移和監管程序的修改。這些變化對大流行病管理有短期影響，對診斷技術和醫療服務有長期影響。

俄烏戰爭影響分析

俄羅斯-烏克蘭戰爭估計對全球診斷設備市場的影響很小，因為該地區的流行率低，而且沒有關鍵的市場參與者。然而，在預測期內，原料、測試產品和設備的進出口的影響預計對全球診斷設備市場的影響不大。

人工智慧影響分析

人工智慧預計將對全球子癇前期市場產生積極的影響。人工智慧診斷小工具可以在治療效果通常較好的時候更早診斷出疾病。這些設備可以持續監測和分析病人數據，允許即時檢測健康指數的異常或變化。早期發現可以迅速採取行動，這可能會減少疾病的發展並改善預後。

目錄

第一章：方法和範圍

  • 研究方法
  • 報告的研究目標和範圍

第二章：定義和概述

第三章：執行摘要

  • 按產品類型分類的摘要
  • 按應用分類的摘要
  • 按終端用戶分類
  • 按地區分類

第四章：動態變化

  • 影響因素
    • 驅動因素
      • 慢性疾病發病率的上升
      • 醫學影像先進技術的應用增加
    • 限制因素
      • 昂貴的程序和設備
    • 機會
      • 技術的進步為診斷設備提供了新的可能性
    • 影響分析

第五章：行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 未滿足的需求
  • 監管分析

第六章：COVID-19分析

  • 對COVID-19的分析
    • COVID-19之前的情況
    • COVID-19期間的情況
    • 後COVID-19或未來的情況
  • 在COVID-19期間的定價動態
  • 需求-供應譜系
  • 大流行期間與市場有關的政府計劃
  • 製造商的戰略計劃
  • 結語

第7章：俄羅斯-烏克蘭戰爭分析

第八章：人工智慧影響分析

第九章：按產品類型分類

  • X光成像系統
    • X光數位成像系統
    • X光模擬成像系統
  • 電腦斷層掃描（CT）掃描儀
    • 傳統的CT系統
    • 錐形束CT系統（CBCT）
  • 超音波系統
    • 二維超聲
    • 3D和四維超聲
    • 多普勒超聲
  • 磁共振成像（MRI）系統
    • 封閉式磁共振成像
    • 開放式磁共振成像
  • 核成像系統
  • SPECT系統
  • 混合PET系統
  • 乳房造影系統

第十章：按應用分類

  • 骨科
  • 神經病學
  • 腫瘤學
  • 產科/婦科
  • 心臟科
  • 牙科
  • 其他

第十一章：按終端用戶

  • 醫院
  • 診斷成像中心
  • 其他

第十二章：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第13章：競爭格局

  • 競爭格局
  • 市場佔有率分析
  • 合併和收購分析

第十四章：公司簡介

  • GE Healthcare
    • 公司概述
    • 產品組合和描述
    • 財務概況
    • 主要發展情況
  • Siemens Healthineers
  • Koninklijke Philips NV
  • Canon Medical Systems Corporation
  • Carestream Health, Inc
  • Hologic, Inc
  • Allengers Medical Systems
  • SternMed
  • Neusoft Medical Systems
  • Medtronic Plc.

第十五章：附錄

簡介目錄
Product Code: MD4437

Market Overview

The Global Diagnostic Device Market reached US$ 47 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 79.9 billion by 2030. The market is expected to exhibit a CAGR of 6.9% during the forecast period 2023-2030.

Diagnostic devices play a pivotal role in healthcare by enabling early detection, accurate diagnosis, monitoring of diseases, personalized treatment, public health surveillance, and research. Diagnostic devices provide objective and precise information, assisting healthcare professionals in making accurate diagnoses. Diagnostic devices enable the monitoring of diseases and conditions over time, helping healthcare providers assess the effectiveness of treatments and make necessary adjustments.

MarketDynamics

The Rise in chronic disease prevalence is driving the growth of the Diagnostic Device Market.

Chronic diseases are long-term health issues that necessitate continuing management and medical care. They are a major worldwide health concern with far-reaching consequences for individuals, healthcare systems, and society. Chronic diseases are the biggest cause of death and disability around the world.

Noncommunicable diseases (NCDs), which include chronic diseases such as cardiovascular disease, cancer, chronic respiratory diseases, and diabetes, account for nearly 75% of all deaths worldwide, according to the World Health Organisation (WHO). Diabetes, on the other hand, is a chronic metabolic condition characterised by elevated blood sugar levels.

According to the International Diabetes Federation, roughly 463 million adults (20-79 years) had diabetes in 2019, and this figure is expected to climb to 700 million by 2045 if current trends continue. And these factors contribute to market expansion.

Expensive procedures and equipment will hamper the market growth.

The cost of diagnostic devices can vary significantly depending on various factors, including the type of device, its complexity, features, brand, and the region in which it is being purchased. For instance, Ultrasound machines use sound waves to produce images of the body's internal structures. The cost of ultrasound machines can vary significantly depending on their intended use and features. Portable or handheld ultrasound devices may range from $3,000 to $15,000, while high-end, cart-based systems used in medical facilities can cost tens of thousands or more. And thus the cost of procedures will hamper the market growth.

COVID-19 Impact Analysis

The pandemic of COVID-19 has had an extensive effect on diagnostic devices and their use. For example, the pandemic prompted a hitherto unheard-of demand for COVID-19 diagnostic testing. COVID-19 infections have been detected and diagnosed using diagnostic tools such as PCR equipment and rapid antigen assays. The increased demand for testing has increased the manufacturing and use of these devices worldwide.

The COVID-19 pandemic has substantially impacted the diagnostic device landscape, resulting in increased demand, technological advances, supply chain issues, shifts in focus, and regulatory procedure modifications. These changes have short-term ramifications for pandemic management and long-term implications for diagnostic technologies and healthcare delivery.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global diagnostic device market owing to the low prevalence and absence of key market players in this region. However, the effect of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global diagnostic device market in the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact the global preeclampsia market positively. AI-enabled diagnostic gadgets can diagnose diseases earlier when treatment outcomes are usually better. These devices can continually monitor and analyze patient data, allowing for real-time detection of irregularities or changes in health indices. Early discovery allows quick action, which may reduce illness development and improve prognosis.

Segment Analysis

The Global Diagnostic Device Market is segmented based on product type, application, end-user and region.

The ultrasound systems segment is estimated to hold most of the diagnostic device market share during the forecast period.

The ultrasound systems ' product type holds about 38.6% of the total diagnostic device market in the forecast period. Ultrasound systems are versatile diagnostic equipment that generates real-time images of the body's internal components using high-frequency sound waves.

They are commonly employed in a variety of medical professions and clinical situations. In radiology, ultrasound is commonly used to evaluate various organs and tissues. It's perfect for imaging soft tissues, including the liver, kidneys, gallbladder, spleen, and thyroid.

And manufacturers are launching new products and highly investing by collaborating with other players to expand their portfolio globally.For instance, on August 26, 2021, Probo Medical, a global leader in medical imaging equipment, parts, repair, and service, has agreed to become an authorised distributor of Mindray North America's ultrasound solutions.

Probo will provide clinicians with immediate and direct access to a wide range of Mindray's unique, category-leading ultrasound imaging instruments and accompanying accessories as a result of this collaboration. And as a result, the market is driven by the leading players' product launches.

Geographical Analysis

During the forecast period, Europe is estimated to hold the second-largest Global Diagnostic Device Market share.

Europe holds the second-largest Global Diagnostic Device Market share, accounting for approximately 28.9% in the forecast period. The greying of Europe is a demographic phenomenon typified by a decline in fertility, a decrease in mortality rate, and a higher life expectancy among European populations. Furthermore, Europe's population is quickly aging, with a growing number of older people.

People's chance of developing chronic diseases such as cardiovascular disease, cancer, diabetes, and respiratory ailments rises as they age. The aging population places a substantial strain on healthcare systems in terms of managing and treating chronic illnesses. For instance, according to World Economic Forum 2022, the European Union and other countries will likely face rapidly aging populations. By 2100, more than 30% of the EU population will be 65 or older. This demographic shift can potentially alter the region's economic prospects significantly.

Competitive Landscape

The major global players in the market include: GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V, Canon Medical Systems Corporation, Carestream Health, Inc, Hologic, Inc, Allengers Medical Systems, SternMed, Neusoft Medical Systems, Medtronic Plc, among others.

Why Purchase the Report?

  • To visualize the Global Diagnostic Device Market segmentation based on product type, application, end user and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous diagnostic device market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Diagnostic Device Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Chronic Diseases
      • 4.1.1.2. Increased Adoption of Advanced Technologies in Medical Imaging
    • 4.1.2. Restraints
      • 4.1.2.1. Expensive Procedures and Equipment
    • 4.1.3. Opportunity
      • 4.1.3.1. Advances in technology have opened up new possibilities in diagnostic devices
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario before COVID-19
    • 6.1.2. Scenario during COVID-19
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Impact Analysis

9. By Product type Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 9.1.2. Market Attractiveness Index, By Product type
  • 9.2. X-ray Imaging Systems
    • 9.2.1. X-ray Digital Imaging Systems
    • 9.2.2. X-ray Analog Imaging Systems
    • 9.2.3. Introduction
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Computed Tomography (CT) Scanners
    • 9.3.1. Conventional CT systems
    • 9.3.2. Cone Beam CT Systems (CBCT)
  • 9.4. Ultrasound Systems
    • 9.4.1. 2D Ultrasound
    • 9.4.2. 3D and 4D Ultrasound
    • 9.4.3. Doppler Ultrasound
  • 9.5. Magnetic Resonance Imaging (MRI) Systems
    • 9.5.1. Closed MRI
    • 9.5.2. Open MRI
  • 9.6. Nuclear Imaging Systems
  • 9.7. SPECT Systems
  • 9.8. Hybrid PET Systems
  • 9.9. Mammography Systems

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Orthopedic
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Neurology
  • 10.4. Oncology
  • 10.5. Obstetrics/Gynecology
  • 10.6. Cardiology
  • 10.7. Dental
  • 10.8. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Hospitals
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Diagnostic Imaging Centers
  • 11.4. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.6.1. The U.S.
      • 12.2.6.2. Canada
      • 12.2.6.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.6.1. Germany
      • 12.3.6.2. The U.K.
      • 12.3.6.3. France
      • 12.3.6.4. Italy
      • 12.3.6.5. Spain
      • 12.3.6.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.6.1. Brazil
      • 12.4.6.2. Argentina
      • 12.4.6.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.6.1. China
      • 12.5.6.2. India
      • 12.5.6.3. Japan
      • 12.5.6.4. Australia
      • 12.5.6.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. GE Healthcare
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Siemens Healthineers
  • 14.3. Koninklijke Philips N.V
  • 14.4. Canon Medical Systems Corporation
  • 14.5. Carestream Health, Inc
  • 14.6. Hologic, Inc
  • 14.7. Allengers Medical Systems
  • 14.8. SternMed
  • 14.9. Neusoft Medical Systems
  • 14.10. Medtronic Plc.

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us